PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial

Name: PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial
Creator: University of Glasgow
Published: 2026-09-16T10:28:18.000Z
License: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

University of Glasgow Published 16 Sept 2026 Public Contracts Scotland Open until 19 Oct 2026

key details

Status	active
Category (CPV)	33600000 +1 more
Region	Scotland
Deadline	19 Oct 2026
Procedure	selective
OCID	ocds-h6vhtk-06faf0

description

PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial, (Including Final Qualified Person Release, Storage and Distribution to Study Sites) and Option to Provide an Integrated IRT System with Forecasting Capabilities.

This procurement process is being conducted using the Competitive Procedure with Negotiation (CPN) in accordance with the requirements of Regulation 30 of the PC(S)R 2015. Although this procurement is being conducted under the Competitive Procedure with Negotiation (CPN), it is structured differently from a typical CPN process. This approach has been adopted to enhance the efficiency of evaluating supplier responses across both stages (SPD and ITT).

Tender documents available from Public Contracts Scotland.

Tender returns should be submitted via Public Contracts Scotland, no paper copies will be accepted. Should paper tenders be submitted, they will be rejected. Further to this any questions or communications regarding individual tender exercises must be sent via the Public Contracts Scotland Portal. Tender queries received through any other channel will not be answered. Should users of Public Contracts Scotland have any problems with the web site they should contact website Support Desk, contact details can be found by following the ‘Contact Us’ option on the left hand menu at http://www.publiccontractsscotland.gov.uk/default.aspx

documents

PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial , contractNotice

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

Published	Type	Regime	Notice
16 Sept 2026	Contract notice (F02)	Earlier regulations	087673-2026

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000

source

Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.